Ger H. Koek

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

From lipofuscin accumulation to cellular dysfunction: a focus on liver pathophysiology.

From lipofuscin accumulation to cellular dysfunction: a focus on liver pathophysiology.

Journal: Histochemistry and cell biology

Published: April 22, 2026

Estradiol negatively associates with metabolic dysfunction-associated steatotic liver disease in children.

Estradiol negatively associates with metabolic dysfunction-associated steatotic liver disease in children.

Journal: Frontiers in endocrinology

Published: March 27, 2026

Towards a Better Understanding of MASLD: Patient Health Literacy, Illness Perception, and Awareness.

Towards a Better Understanding of MASLD: Patient Health Literacy, Illness Perception, and Awareness.

Journal: Diseases (Basel, Switzerland)

Published: March 11, 2026

Letter to the Editor: MASLD In Adults With Type 1 Versus Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography.

Letter to the Editor: MASLD In Adults With Type 1 Versus Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 17, 2026

Vitamin D Sufficiency Revisited: Evidence of a Dose-Response Effect for MASLD in Adults at Risk.

Vitamin D Sufficiency Revisited: Evidence of a Dose-Response Effect for MASLD in Adults at Risk.

Journal: Nutrients

Published: December 12, 2025

Is FIB-4 the right tool for screening for liver fibrosis?

Is FIB-4 the right tool for screening for liver fibrosis?

Journal: Annals of hepatology

Published: November 10, 2025

Assessing Hepatic Steatosis Following Weight Loss in Adolescents with Severe Obesity: A Randomized Controlled Trial.

Assessing Hepatic Steatosis Following Weight Loss in Adolescents with Severe Obesity: A Randomized Controlled Trial.

Journal: Children (Basel, Switzerland)

Published: October 19, 2025

Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The Netherlands.

Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The Netherlands.

Journal: Biomedicines

Published: October 14, 2025

Prevalence of MASLD and fibrosis in Turkey: Results from a multicenter study of at-risk populations.

Prevalence of MASLD and fibrosis in Turkey: Results from a multicenter study of at-risk populations.

Journal: PloS one

Published: October 09, 2025

Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial.

Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial.

Journal: Hepatology communications

Published: August 18, 2025

Pros and cons of different dietary patterns for the treatment of metabolic dysfunction-associated steatotic liver disease.

Pros and cons of different dietary patterns for the treatment of metabolic dysfunction-associated steatotic liver disease.

Journal: Metabolism: clinical and experimental

Published: July 05, 2025

The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease.

The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease.

Journal: Lipids in health and disease

Published: September 13, 2024

Showing 1-12 of 127

Last Updated: 09/26/2026